Progress in Neuro-Psychopharmacology & Biological Psychiatry

Papers
(The H4-Index of Progress in Neuro-Psychopharmacology & Biological Psychiatry is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Younger people are more vulnerable to stress, anxiety and depression during COVID-19 pandemic: A global cross-sectional survey432
COVID-19 pandemic impact on children and adolescents' mental health: Biological, environmental, and social factors395
Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies248
The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses181
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease132
The impact of COVID-19 lockdown on social network sites use, body image disturbances and self-esteem among adolescent and young women119
Psychological effects caused by the COVID-19 pandemic in health professionals: A systematic review with meta-analysis119
Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health professionals working in patients affected by COVID-19: A systematic review with meta-analysis109
Prevalence of anxiety in health care professionals during the COVID-19 pandemic: A rapid systematic review (on published articles in Medline) with meta-analysis100
Mental health consequences of the Covid-19 outbreak in Spain. A longitudinal study of the alarm situation and return to the new normality98
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review97
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences90
Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis83
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence78
Gambling and the COVID-19 pandemic: A scoping review69
Consequences of the COVID-19 pandemic on admissions to general hospital psychiatric wards in Italy: Reduced psychiatric hospitalizations and increased suicidality66
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present62
Graph theory approach for the structural-functional brain connectome of depression60
Gut microbiota-derived vitamins – underrated powers of a multipotent ally in psychiatric health and disease59
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach58
Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation58
Depression: Biological markers and treatment57
BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment54
Exploring the role of neuropeptides in depression and anxiety54
Role of interleukin 8 in depression and other psychiatric disorders54
Anorexia nervosa and gut microbiota: A systematic review and quantitative synthesis of pooled microbiological data53
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis53
Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-1952
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression51
The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis50
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects48
Psychologic distress and sleep quality among adults in Turkey during the COVID-19 pandemic48
Gut-brain axis: A matter of concern in neuropsychiatric disorders…!47
Efficacy and tolerability of theta-burst stimulation for major depression: A systematic review and meta-analysis46
Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression46
Philosophy for children and mindfulness during COVID-19: Results from a randomized cluster trial and impact on mental health in elementary school students45
Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder44
Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression44
Neural substrates for late-life depression: A selective review of structural neuroimaging studies44
Gut microbiota, kynurenine pathway and mental disorders – Review43
Effects of acute and chronic arecoline in adult zebrafish: Anxiolytic-like activity, elevated brain monoamines and the potential role of microglia43
Biological rhythms and chronotherapeutics in depression43
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD42
The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders42
0.098433017730713